CN115124410A - Preparation method of 2-fluoro-4-hydroxybenzaldehyde - Google Patents

Preparation method of 2-fluoro-4-hydroxybenzaldehyde Download PDF

Info

Publication number
CN115124410A
CN115124410A CN202210971692.9A CN202210971692A CN115124410A CN 115124410 A CN115124410 A CN 115124410A CN 202210971692 A CN202210971692 A CN 202210971692A CN 115124410 A CN115124410 A CN 115124410A
Authority
CN
China
Prior art keywords
fluoro
hydroxybenzaldehyde
isopropoxybenzene
producing
dmf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210971692.9A
Other languages
Chinese (zh)
Inventor
蒋道来
熊诗传
王放
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Kehua Biotechnology Co ltd
Original Assignee
Shanghai Kehua Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Kehua Biotechnology Co ltd filed Critical Shanghai Kehua Biotechnology Co ltd
Priority to CN202210971692.9A priority Critical patent/CN115124410A/en
Publication of CN115124410A publication Critical patent/CN115124410A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/16Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/02Magnesium compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention discloses a preparation method of 2-fluoro-4-hydroxybenzaldehyde, belonging to the technical field of organic synthesis. Protecting hydroxyl by taking 3-fluorophenol as a raw material, then bromizing with a bromination reagent, then carrying out Grignard reagent exchange and DMF (dimethyl formamide) reaction to generate corresponding aldehyde, and finally carrying out deprotection and purification to obtain 2-fluoro-4-hydroxybenzaldehyde. The method has the advantages of easily obtained raw materials, low cost, mild and continuous reaction conditions, low requirement on equipment and high product purity of 99.5 percent, and optimizes the final process by screening different phenolic hydroxyl protecting groups and finally selecting isopropyl as the protecting group.

Description

Preparation method of 2-fluoro-4-hydroxybenzaldehyde
Technical Field
The invention relates to a preparation method of 2-fluoro-4-hydroxybenzaldehyde, belonging to the technical field of organic synthesis.
Background
2-fluoro-4-hydroxybenzaldehyde, english name: 2-fluoro-4-hydroxybenzaldehyde, CAS 348-27-6, 2-fluoro-4-hydroxybenzaldehyde is mainly applied to intermediates of physiologically active compounds such as medicines or pesticides and the like, is a wide range of organic block compounds, and has a structure containing fluorine, aldehyde group and phenolic hydroxyl group which can be added or substituted for other functional groups.
At present, fluorine-containing medicines are developed most actively, and hundreds of products are commercialized or developed. The literature [ Bioorganic and Medicinal Chemistry Letters,2010,20, 153-; the literature [ RSC Advances,2016,6, 95177-; the synthesis of novel melanin concentrating hormone receptor antagonists via 2-fluoro-4-hydroxybenzaldehyde as an intermediate is described in the Journal of Medi ci-al Chemistry,2016,59, 2497-2511. WO2016/22742,2016, A1 also uses 2-fluoro-4-hydroxybenzaldehyde as intermediate to synthesize fused tricyclic imidazole-containing medicines.
However, the synthesis of 2-fluoro-4-hydroxybenzaldehyde is not limited, among them [ Journal of Fluo rine Chemistry,1995,70,39-44]The method adopts 3-fluorophenol and tert-butyldimethylsilyl chloride to react for protecting hydroxyl, then adopts sec-butyllithium to react with DMF after ultra-low temperature hydrogen extraction to generate aldehyde, and then obtains deprotection under acidic condition to obtain 2-fluoro-4-hydroxybenzaldehyde. The reaction equation is as follows:
Figure BDA0003796428610000011
the method has short steps, the total yield reaches 68.4%, but the used reagents are expensive, require ultralow temperature reaction, have high requirements on equipment and are not beneficial to large-scale production.
The general route is all protected with a 3-fluorophenol hydroxyl group followed by a butyllithium/DMF aldehyde group followed by deprotection to give 2-fluoro-4-hydroxybenzaldehyde. The method screens out the protective group which is low in price and easy to remove through experimental optimization, has moderate steric hindrance, is beneficial to fluorine ortho-position bromination, has mild and continuous reaction conditions, does not need ultralow temperature, has low requirements on equipment and high quality, is suitable for industrial production, and meets the increasing market demand.
Disclosure of Invention
In order to overcome the technical defects, the invention provides a preparation method of 2-fluoro-4-hydroxybenzaldehyde. Protecting hydroxyl by taking 3-fluorophenol as a raw material, then brominating with a bromination reagent, then carrying out Grignard reagent exchange to react with DMF to generate corresponding aldehyde, finally removing phenolic hydroxyl protection, and further purifying to obtain 2-fluoro-4-hydroxybenzaldehyde. The method has the advantages of easily obtained raw materials, low cost, mild and continuous reaction conditions, low requirement on equipment and high product purity of 99.5 percent, and optimizes the final process by screening different phenolic hydroxyl protecting groups and finally selecting isopropyl as the protecting group.
The invention relates to a preparation method of 2-fluoro-4-hydroxybenzaldehyde, which has the following reaction equation:
Figure BDA0003796428610000021
the method comprises the following steps:
the first step is as follows: mixing 3-fluorophenol, potassium carbonate and 2-bromopropane in an organic solvent, and heating to react with 1-fluoro-3-isopropoxybenzene;
the second step is that: dissolving 1-fluoro-3-isopropoxybenzene in an organic solvent, and reacting with a bromization reagent to obtain 1-bromo-2-fluoro-4-isopropoxybenzene;
the third step: dissolving 1-bromo-2-fluoro-4-isopropoxybenzene in tetrahydrofuran, dropwise adding an isopropyl magnesium chloride/tetrahydrofuran solution at-10 to 0 ℃, and adding DMF (dimethyl formamide) for reaction after Grignard exchange to obtain 2-fluoro-4-isopropoxybenzaldehyde;
the fourth step: reacting 2-fluoro-4-isopropoxybenzaldehyde with boron trichloride, and deprotecting to obtain 2-fluoro-4-hydroxybenzaldehyde.
Further, in the above technical solution, the organic solvent in the first step is selected from acetonitrile, acetone, tetrahydrofuran or DMF.
Further, in the technical scheme, the molar ratio of the 3-fluorophenol, the potassium carbonate and the 2-bromopropane in the first step is 1: 1.80-2.30: 1.20-1.40.
Further, in the above technical solution, the brominating reagent in the second step is selected from tetrabutyl ammonium tribromide or pyridinium tribromide.
Further, in the above technical solution, the organic solvent in the second step is selected from 1, 2-dichloroethane or dichloromethane.
Further, in the above technical scheme, the molar ratio of the 1-fluoro-3-isopropoxybenzene to the brominating agent in the second step is 1: 0.98-1.05.
Further, in the technical scheme, the molar ratio of the 1-bromo-2-fluoro-4-isopropoxybenzene, isopropyl magnesium chloride and DMF in the third step is 1: 1.15-1.20: 1.25-1.35.
Further, in the above technical solution, the molar ratio of the 2-fluoro-4-isopropoxybenzaldehyde to boron trichloride in the fourth step is 1: 2-5.5.
Advantageous effects of the invention
1. Through screening of phenolic hydroxyl protecting groups, bromination is carried out on protecting groups of methyl, ethyl, isopropyl, tert-butyl and THP (2-tetrahydropyran), the methyl and ethyl protecting groups have more isomers when being brominated, the tert-butyl protecting group has the least brominated isomer, but the tert-butyl bromide is expensive and is not easy to be protected, the THP is easy to be deprotected during the bromination reaction, and through screening of different bromination reagents, the bromination reaction of different phenolic hydroxyl protecting groups finds that dibromohydantoin, tetrabutyl ammonium tribromide or pyridinium tribromide has less isomers, and tetrabutyl ammonium tribromide is preferred. By deprotection with boron trichloride at low temperature, isomers can be recrystallized and purified. In conclusion, the price of the 2-bromopropane is relatively low, isomers are relatively few when the isopropyl protecting group is brominated, boron trichloride is adopted during deprotection, the conditions are more appropriate to heat, and the yield is higher.
2. Ultralow temperature reaction is avoided in the whole process, the reaction condition is mild, the intermediate does not need to be purified through the property analysis of impurities, and finally the obtained product has the purity of more than 99.5 percent through the recrystallization of isopropyl ether.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The invention is further illustrated by the following specific examples. These examples are to be construed as merely illustrative and not limitative of the remainder of the disclosure in any way whatsoever. After reading the description of the present invention, one skilled in the art can make various changes and modifications to the invention, and these equivalent changes and modifications also fall into the scope of the invention defined by the claims.
Example 1
Figure BDA0003796428610000041
5.6g (0.05mol,1eq) of 3-fluorophenol, 20.7g (0.15mol,3eq) of ground potassium carbonate and 60mL of acetonitrile are mixed, 8.8g (0.07mol,1.4eq) of dimethyl sulfate is slowly dropped at 30-35 ℃, then the temperature is raised to 80-82 ℃ for reaction for 4 hours, HPLC detects 2 percent of the raw material remained, water and ethyl acetate are added when the temperature is lowered to room temperature, an organic phase is separated, the organic phase is washed by water and saturated sodium chloride, anhydrous sodium sulfate is dried, and the organic phase is concentrated to obtain 6.03g of 1-fluoro-3-methoxybenzene. HPLC 94.5%, yield 95.6%. 1 HNMR(400MHz,CDCl3):7.73-7.69(m,1H),7.45-7.41(m,1H),7.15-7.11(m,1H),6.71-6.68(m,1H),3.81(s,3H).
Under the protection of nitrogen, mixing 5.0g (0.04mol,1eq) of 1-fluoro-3-methoxybenzene with 50mL of dichloromethane, cooling to 10 ℃, slowly dropwise adding a solution containing 6.4g (0.04mol,1eq) of bromine/5 mL of dichloromethane, detecting the residual 3% of raw materials by HPLC, adding ice water, adding sodium carbonate solid in batches to adjust the pH to 8-9, carrying out layering, extracting an aqueous phase with dichloromethane, combining organic phases, washing the organic phases with water and saturated sodium chloride respectively, drying the organic phases by using anhydrous sodium sulfate, concentrating the organic phases, carrying out HPLC (high performance liquid chromatography), and carrying out column chromatography on ethyl acetate: n-heptane ═ 1: 10-1: 5 elution gave 3.7g of 1-bromo-2-fluoro-4-methoxybenzene in 44.9% yield, HPLC 97.3%. 1 HNMR(400MHz,CDCl3):7.45-7.40(m,1H),7.01-6.97(m,1H),6.64-6.60(m,1H),3.78(s,3H).
Example 2
Figure BDA0003796428610000051
5.6g (0.05mol,1eq) of 3-fluorophenol, 20.7g (0.15mol,3eq) of ground potassium carbonate and 60mL of acetonitrile are mixed, 10.8g (0.07mol,1.4eq) of diethyl sulfate is slowly dropped at 30-35 ℃, then the temperature is increased to 80-82 ℃ for reaction for 6 hours, HPLC detects the residual 2 percent of raw materials, and the temperature is reduced to room temperatureWater and ethyl acetate were added to the reaction mixture, and the organic phase was separated, washed with water and saturated sodium chloride, dried over anhydrous sodium sulfate, and concentrated to give 6.7g of 1-fluoro-3-ethoxybenzene, HPLC 93.7%, yield 96.0%. 1 HNMR(400MHz,CDCl3):7.71-7.68(m,1H),7.44-7.40(m,1H),7.14-7.10(m,1H),6.63-6.60(m,1H),4.02-3.99(m,2H),1.38-1.34(m,3H).
Under the protection of nitrogen, 5.6g (0.04mol,1eq) of 1-fluoro-3-ethoxybenzene is mixed with 50mL of dichloromethane, the temperature is reduced to 10 ℃, 7.1g (0.04mol,1eq) of NBS is added in batches, the residual 3 percent of raw materials is detected by HPLC, ice water is added, sodium carbonate solid is added in batches to adjust the pH value to be 8-9 for layering, dichloromethane in an aqueous phase is extracted, an organic phase is combined, the organic phase is washed by water and saturated sodium chloride, anhydrous sodium sulfate is dried, the organic phase is concentrated and is subjected to HPLC 71%, and column chromatography ethyl acetate/n-heptane 1/10 is eluted to obtain 5.3g of 1-bromo-2-fluoro-4-ethoxybenzene, the yield is 60.3 percent, and the HPLC is 96.8 percent. 1 H NMR(400MHz,CDCl3):7.44-7.38(m,1H),6.91-6.87(m,1H),6.60-6.58(m,1H),4.01-3.98(m,2H),1.40-1.37(m,3H).
Example 3
Figure BDA0003796428610000061
5.6g (0.05mol,1eq) of 3-fluorophenol, 15.9g (0.115mol,2.3eq) of ground potassium carbonate and 60mL of acetonitrile are mixed, 8.7g (0.07mol,1.4eq) of 2-bromopropane is slowly dropped at 30-35 ℃, then the temperature is increased to 80-82 ℃ for reaction for 14 hours, HPLC detects the residual 2 percent of raw materials, water and ethyl acetate are added after the temperature is reduced to room temperature, an organic phase is separated, the organic phase is washed by water and saturated sodium chloride, anhydrous sodium sulfate is dried, the organic phase is concentrated to obtain 7.5g of 1-fluoro-3-isopropoxybenzene, the HPLC is 95.7 percent, and the yield is 97.1 percent. 1 HNMR(400MHz,CDCl3):7.64-7.60(m,1H),7.40-7.35(m,1H),7.10-7.06(m,1H),6.59-6.55(m,1H),4.51-4.46(m,1H),1.37-1.33(m,6H).
Mixing 5.6g (0.04mol,1eq) of 1-fluoro-3-isopropoxybenzene with 50mL of dichloromethane under the protection of nitrogen, cooling to 10 ℃, adding 11.4g (0.04mol,1eq) of dibromohydantoin in batches, detecting the residual 2 percent of raw materials by HPLC, adding ice water, adding sodium carbonate in batches to adjust the pH to 9, demixing, and adding waterThe phases were extracted with dichloromethane, the organic phases were combined, washed with water and saturated sodium chloride, dried over anhydrous sodium sulfate, and then the organic phase was concentrated, HPLC 88%, column chromatography ethyl acetate/n-heptane ═ 1/10 to give 7.6g of 1-bromo-2-fluoro-4-isopropoxybenzene, yield 81.3%, HPLC 98.1%. 1 HNMR(400MHz,CDCl3):7.44-7.32(m,1H),6.87-6.84(m,1H),6.58-6.55(m,1H),4.46-4.42(m,1H),1.33-1.29(m,6H).
Comparative results of protection on hydroxyl test:
Figure BDA0003796428610000071
Figure BDA0003796428610000072
bromination reaction test comparison results:
Figure BDA0003796428610000073
Figure BDA0003796428610000074
Figure BDA0003796428610000081
the overall yield of isopropyl protection is determined to be the highest, the price is the lowest and the conditions are mild by the table.
Example 4
Figure BDA0003796428610000082
Under the protection of nitrogen, 15.4g (0.1mol,1eq) of 1-fluoro-3-isopropoxybenzene was mixed with 100mL of 1, 2-dichloroethane, the temperature was controlled to 0-10 ℃, 35.2g (0.099mol,1eq) of 90% pyridinium tribromide was added in portions, the addition was completed, the reaction was carried out for 2 hours, and HPLC detected that 2% of starting material remained. Adding ice water, adding saturated aqueous solution of sodium carbonate to adjust pH to 9, layering, extracting the aqueous phase with 1, 2-dichloroethane, combining the organic phases, washing the organic phase with water and saturated sodium chloride once respectively, drying over anhydrous sodium sulfate, concentrating the organic phase to obtain 22.4g of 1-bromo-2-fluoro-4-isopropoxybenzene, and carrying out HPLC 91% without purification.
Figure BDA0003796428610000083
Under the protection of nitrogen, 15.4g (0.1mol,1eq) of 1-fluoro-3-isopropoxybenzene is mixed with 100mL of 1, 2-dichloroethane, the temperature is controlled to be 0-10 ℃, 49.2g (0.1mol,1eq) of 98% tetrabutylammonium tribromide/50 mL of dichloromethane is added dropwise, the reaction is carried out for 2 hours after the addition is finished, and HPLC detects 1% of the raw material. Adding ice water, adding saturated aqueous solution of sodium carbonate to regulate pH to 9, demixing, extracting the aqueous phase with 1, 2-dichloroethane, combining the organic phases, washing the organic phase with water and saturated sodium chloride once respectively, drying over anhydrous sodium sulfate, concentrating the organic phase to obtain 23.1g of 1-bromo-2-fluoro-4-isopropoxybenzene, performing HPLC (high performance liquid chromatography) on 95.2%, and directly performing the next step without purification.
Example 5
Figure BDA0003796428610000091
Under the protection of nitrogen, 22.4g of 1-bromo-2-fluoro-4-isopropoxybenzene obtained in example 4 and 200mL of tetrahydrofuran are mixed, cooled to-5 ℃, and 60mL of 2.0mol/L isopropyl magnesium chloride tetrahydrofuran solution is slowly added dropwise while controlling the temperature to be-5 ℃ to 0 ℃, and then heated to 5-10 ℃ for reaction for 1 hour. The temperature is reduced to-15 ℃,20 mL of tetrahydrofuran solution containing 9.5g of DMF is added dropwise, then the temperature is slowly raised to room temperature for reaction for 2 hours, 2N hydrochloric acid is quenched, MTBE is extracted, organic phases are combined, washed by saturated sodium chloride, dried by anhydrous sodium sulfate, and concentrated and then distilled under reduced pressure to obtain 17.2g of 2-fluoro-4-isopropoxybenzaldehyde, the HPLC purity of which is 91.2 percent, and the 2-fluoro-4-isopropoxybenzaldehyde is directly used in the next step without purification.
Example 6
Figure BDA0003796428610000092
Under the protection of nitrogen, 17.2g of 2-fluoro-4-isopropoxybenzaldehyde obtained in example 5 and 200mL of dichloromethane were mixed, 49.2g of boron trichloride was introduced at-15 ℃ to 0 ℃ and the temperature was controlled to-15 ℃ to-10 ℃ to react for 2 hours. Pouring ice water into the mixture, adding sodium carbonate solid to adjust the pH value to be 6-7, then adding concentrated hydrochloric acid to adjust the pH value to be 1-2, obviously layering, extracting an aqueous phase by using dichloromethane, washing an organic phase by using saturated salt water, drying by using anhydrous sodium sulfate, concentrating, then carrying out reduced pressure distillation to obtain 13.3g of a crude product of the 2-fluoro-4-hydroxybenzaldehyde, adding 80g of isopropyl ether, heating to 60-65 ℃ for recrystallization to obtain 10.7g of 2-fluoro-4-hydroxybenzaldehyde, wherein the HPLC purity is 99.6%, and the yield is 76.4%. ESI-MS, M/z 139[ M-H ]]。 1 H NMR(400MHz,CDCl3):10.34(s,1H),9.45(s,1H),7.54-7.41(m,2H),6.88-6.85(m,1H).
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be able to cover the technical solutions and the inventive concepts of the present invention within the technical scope of the present invention.

Claims (8)

1. A preparation method of 2-fluoro-4-hydroxybenzaldehyde is characterized by comprising the following steps:
Figure FDA0003796428600000011
the first step is as follows: mixing 3-fluorophenol, potassium carbonate and 2-bromopropane in an organic solvent, and heating to react to obtain 1-fluoro-3-isopropoxybenzene;
the second step is that: dissolving 1-fluoro-3-isopropoxybenzene in an organic solvent, and reacting with a bromination reagent to obtain 1-bromo-2-fluoro-4-isopropoxybenzene;
the third step: dissolving 1-bromo-2-fluoro-4-isopropoxybenzene in tetrahydrofuran, dropwise adding an isopropyl magnesium chloride/tetrahydrofuran solution at-10 to 0 ℃, and adding DMF (dimethyl formamide) for reaction after Grignard exchange to obtain 2-fluoro-4-isopropoxybenzaldehyde;
the fourth step: reacting 2-fluoro-4-isopropoxybenzaldehyde with boron trichloride, and deprotecting to obtain 2-fluoro-4-hydroxybenzaldehyde.
2. The method for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the first step, the organic solvent is selected from acetonitrile, acetone, tetrahydrofuran or DMF.
3. The method for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the first step, the molar ratio of the 3-fluorophenol, the potassium carbonate and the 2-bromopropane is 1: 1.80-2.30: 1.20-1.40.
4. The process for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the second step, the brominating agent is selected from tetrabutyl ammonium tribromide or pyridinium tribromide.
5. The process for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the second step, the organic solvent is selected from 1, 2-dichloroethane or dichloromethane.
6. The process for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the second step, the molar ratio of the 1-fluoro-3-isopropoxybenzene to the brominating agent is 1: 0.98-1.05.
7. The process for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the third step, the molar ratio of the 1-bromo-2-fluoro-4-isopropoxybenzene, isopropyl magnesium chloride and DMF is 1: 1.15-1.20: 1.25-1.35.
8. The process for producing 2-fluoro-4-hydroxybenzaldehyde according to claim 1, characterized in that: in the fourth step, the molar ratio of the 2-fluoro-4-isopropoxybenzaldehyde to boron trichloride is 1: 2- -5.5.
CN202210971692.9A 2022-08-13 2022-08-13 Preparation method of 2-fluoro-4-hydroxybenzaldehyde Pending CN115124410A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210971692.9A CN115124410A (en) 2022-08-13 2022-08-13 Preparation method of 2-fluoro-4-hydroxybenzaldehyde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210971692.9A CN115124410A (en) 2022-08-13 2022-08-13 Preparation method of 2-fluoro-4-hydroxybenzaldehyde

Publications (1)

Publication Number Publication Date
CN115124410A true CN115124410A (en) 2022-09-30

Family

ID=83386116

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210971692.9A Pending CN115124410A (en) 2022-08-13 2022-08-13 Preparation method of 2-fluoro-4-hydroxybenzaldehyde

Country Status (1)

Country Link
CN (1) CN115124410A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0352839A (en) * 1989-07-19 1991-03-07 Hokko Chem Ind Co Ltd Production of p-or m-tert-butoxybenzaldehyde
US20090131433A1 (en) * 2005-06-22 2009-05-21 Pfizer Inc. Histamine-3 receptor antagonists
CN102574788A (en) * 2009-09-24 2012-07-11 弗·哈夫曼-拉罗切有限公司 Indole derivatives as crac modulators
CN105814046A (en) * 2013-12-09 2016-07-27 Ucb生物制药私人有限公司 Imidazopyridine derivatives as modulators of TNF activity
CN105859536A (en) * 2016-05-06 2016-08-17 蚌埠中实化学技术有限公司 Method for preparing 3, 4-difluorobenzaldehyde
WO2022051596A1 (en) * 2020-09-03 2022-03-10 Orexia Therapeutics Limited Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
CN114671747A (en) * 2022-04-08 2022-06-28 浙江永太科技股份有限公司 Synthesis method of 4-chloro-2-fluorobenzaldehyde

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0352839A (en) * 1989-07-19 1991-03-07 Hokko Chem Ind Co Ltd Production of p-or m-tert-butoxybenzaldehyde
US20090131433A1 (en) * 2005-06-22 2009-05-21 Pfizer Inc. Histamine-3 receptor antagonists
CN102574788A (en) * 2009-09-24 2012-07-11 弗·哈夫曼-拉罗切有限公司 Indole derivatives as crac modulators
CN105814046A (en) * 2013-12-09 2016-07-27 Ucb生物制药私人有限公司 Imidazopyridine derivatives as modulators of TNF activity
CN105859536A (en) * 2016-05-06 2016-08-17 蚌埠中实化学技术有限公司 Method for preparing 3, 4-difluorobenzaldehyde
WO2022051596A1 (en) * 2020-09-03 2022-03-10 Orexia Therapeutics Limited Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
CN114671747A (en) * 2022-04-08 2022-06-28 浙江永太科技股份有限公司 Synthesis method of 4-chloro-2-fluorobenzaldehyde

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
L. REGINALD MILLS ET AL.: "Design of an Electron-Withdrawing Benzonitrile Ligand for Ni-Catalyzed Cross-Coupling Involving Tertiary Nucleophiles", 《J. AM. CHEM. SOC.》, vol. 143, 1 July 2021 (2021-07-01), pages 11 *
LUKAS HINTERMANN ET AL.: "Solvent-Controlled Leaving-Group Selectivity in Aromatic Nucleophilic Substitution", 《ORG. LETT.》, vol. 10, no. 21, 9 October 2008 (2008-10-09), pages 3 *
MICHEL MONCLUS ET AL.: "Asymmetric synthesis of fluorinated L-tyrosine and meta-L-tyrosines", 《JOURNAL OF FLUORINE CHEMISTRY》, vol. 70, 31 December 1995 (1995-12-31), pages 40 *

Similar Documents

Publication Publication Date Title
FI80708C (en) Process for selective methylation of derivatives of erythromycin A
CN114524795B (en) Improved rhodozyrtone preparation method
CN115124410A (en) Preparation method of 2-fluoro-4-hydroxybenzaldehyde
US5130472A (en) Total synthesis of erbstatin analogs
CN114195712B (en) Intermediate capable of being used for preparing procaterol hydrochloride and preparation method thereof
CN114105872B (en) Intermediate for preparing procaterol hydrochloride and preparation method thereof
CN110845512B (en) Total synthesis method of triterpenoid natural product (+) -Arisugacins F/G
Ando et al. The total syntheses of chamaecynone, isochamaecynone, and dihydroisochamaecynone.
EP0089037B1 (en) Process for preparing optically active (s)-2-acetyl-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran and salts thereof
Matsumoto et al. The total synthesis of (+)-totarol and (+)-podototarin.
Piers et al. Some substituted 9-phenylxanthen-9-yl protecting groups
CN113387804B (en) Synthesis method of alpha-asarone acetate and alpha-octanol
US4495103A (en) Preparation of optically active 4-demethoxydaunomycinone
Gutzke et al. Synthesis of quercetin-2-C14
JPS61152673A (en) Production of dibenzo(b,e)oxepine derivative
JPS595595B2 (en) Method for producing 15-hydroxyimino-E-homoebrunane derivative
KR19990015053A (en) Method for preparing 2- (4-halomethylphenyl) propionic acid
KR100448642B1 (en) Method for producing phenyl propionic acid derivatives from 2-phenylpropionic acid by simple processing steps with high yield and purity
US4417064A (en) Biphenyl compounds and method of preparing same
WO1998015516A1 (en) Process for the preparation of a pharmaceutical intermediate
KR100448640B1 (en) Method for producing phenyl propionic acid derivatives with high yield and purity
CN114539042A (en) Novel synthesis process of 5-fluoro-2-hydroxyacetophenone
JP3131056B2 (en) Process for producing 2,3-dimethylnaphthalene and intermediates thereof
WO2021058425A1 (en) Method of making and/or isolating isoidide, comprising selective esterification of a mixture of dianhydrohexitol isomers
CN117603167A (en) Preparation method of high-purity D-ribonic lactone

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination